Home > Press > SWR&D Purchases NanoBioMagnetics
 |
| Clinton Herring |
Abstract:
Lawton-based SWR&D, Inc. (SWR&D) has purchased the assets of NanoBioMagnetics, Inc. and its wholly-owned subsidiary, XetaComp from H. Thomas Moran & Associates. The purchase includes all intellectual properties, patents, and patents pending as well as laboratory and production equipment.
NanoBioMagnetics developed nanotechnologies for human health applications. Foremost among these technologies was a nano-scaled platform for the site-specific delivery of chemotherapeutics. According to Clinton Herring, president and CEO of SWR&D, "Our decision to purchase the company was based on the fact that the potential of these technologies were not fully realized under the previous ownership. It is our intention to fully develop these technologies. We are looking forward to continuing a collaboration with MD Anderson in developing this chemotherapeutic delivery system."
SWR&D Purchases NanoBioMagnetics
Lawton, OK | Posted on August 1st, 2012XetaComp had developed technologies and processes for the production of various nano-powders. "Our initial focus will be on the manufacture of a nano-scaled titanium dioxide. We have already contacted a number of potential customers who have requested samples of our product," says Herring. "We are currently in the process of upgrading the lab and production facilities at our Lawton location and hope to be in production within 30 to 60 days."
Included in the purchase were licensing agreements with Nanomateriales in Monterey, Mexico and NanoTherics in Keele, England. "We are in the process of evaluating and re-negotiating these agreements," says Herring.
NanoBioMagnetics was placed in receivership in 2011 as the result of a stockholders' lawsuit.
SWR&D's Lawton facility has approximately 10,000 square feet of office/lab/production space situated on 3 acres.
####
For more information, please click here
Contacts:
Dennis Donaldson
Senior Vice President, Marketing and Communications
102 NE 20th
Lawton, OK 73507
V: 405.706.9687
E:
Copyright © SWR&D, Inc.
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Bookmark:
| Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Powders
Graphene nanotubes offer an efficient replacement for carbon additives in conductive electrical heating paints November 3rd, 2021
NRL reveals novel uniform coating process of p-ALD April 21st, 2016
Ceramics and Nanoceramic Powders Market To 2015: Acute Market Reports July 20th, 2015
Global Nanoclays Market Analysis, Size, Growth, Trends And Segment Forecasts, 2015 To 2022: Grand View Research, Inc June 15th, 2015
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
Acquisitions/Mergers/Splits
180 Degree Capital Corp. Life Science Portfolio Company Enters Into Definitive Agreement to be Acquired May 6th, 2020
180 Degree Capital Corp.’s Portfolio Company, Synacor, Inc., Agrees to Merge with Qumu Corporation in All-Stock Transaction February 11th, 2020
Combination of Nanometrics and Rudolph Technologies to Create Onto Innovation October 16th, 2019
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||